0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 1-20 of 318 Articles
News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(15):1504. doi:10.1001/jama.2014.12463.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(13):1280-1281. doi:10.1001/jama.2013.279755.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(12):1185. doi:10.1001/jama.2014.12756.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10967.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10968.

JAMA Revisited | 
JAMA. 2014;312(8):850. doi:10.1001/jama.2013.279692.

Global Health | 
M. J. Friedrich
JAMA. 2014;312(7):687. doi:10.1001/jama.2014.9498.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(3):223. doi:10.1001/jama.2014.8181.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(2):117-118. doi:10.1001/jama.2014.7731.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(1):19. doi:10.1001/jama.2014.7647.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(1):20. doi:10.1001/jama.2014.6694.

news@JAMA | 
JAMA. 2014;311(22):2263. doi:10.1001/jama.2014.6495.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(21):2159-2160. doi:10.1001/jama.2014.5090.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(21):2162. doi:10.1001/jama.2014.6400.

Research Letter | 
Yaron Finkelstein, MD, ABCP(Dip); Erin M. Macdonald, MSc; Ping Li, PhD; et al.
JAMA. 2014;311(21):2231-2232. doi:10.1001/jama.2014.839.

Viewpoint | 
Chirag J. Patel, PhD; John P. A. Ioannidis, MD, DSc
JAMA. 2014;311(21):2173-2174. doi:10.1001/jama.2014.4129.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(21):2164. doi:10.1001/jama.2014.5481.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(16):1603. doi:10.1001/jama.2014.4489.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(16):1600. doi:10.1001/jama.2014.4483.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
MEK Inhibitor–Induced Dusky Erythema:  Characteristic Drug Hypersensitivity Manifestation in 3 Patients
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatology
Original Investigation  | 
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
JAMA Dermatology
Notable Notes  | 
Arsenicosis:  The Greatest Public Health Disaster in History
Walter H. C. Burgdorf, MD; Leonard J. Hoenig, MD
JAMA Internal Medicine
Research Letter  | 
Presentation of Prescription and Nonprescription Opioid Overdoses to US Emergency Departments
Michael A. Yokell, ScB; M. Kit Delgado, MD, MS; Nickolas D. Zaller, PhD; et al.